Trial intelligence / Profile preview

Effect of L-menthol on Breathlessness and Exercise Capacity in Asthma

NCT07500974Phase 2Recruiting

Sponsor
Region Skåne
Start
May 2026
Primary completion
Apr 2027
Countries
1
01

Overview

Phase 2, randomised trial in asthma comparing L-menthol with Placebo (2 arms). Primary endpoint: Breathlessness intensity at day 3. Started May 2026; status: recruiting.

02

Drugs

l-Menthol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT07500974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07500974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call